龍蟠科技(603906.SH):控股子公司與LGES簽署長期供貨協議
格隆匯2月21日丨龍蟠科技(603906.SH)公佈,控股子公司常州鋰源新能源科技有限公司(簡稱“常州鋰源”)與LG EnergySolution, Ltd.(簡稱“LGES”)簽署了《長期供貨協議》。協議約定,由常州鋰源自2024年至2028年期間合計向LGES銷售16萬噸磷酸鐵鋰正極材料產品,具體單價由雙方根據本協議條款逐月確定,如按照當前市場價格估算,協議總金額超人民幣70億元;此外協議約定,雙方將盡最大努力,在2024年6月30日之前,就2025年至2028年期間額外供銷36萬噸磷酸鐵鋰正極材料產品的事項進行協商與確定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.